US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 6.190
  • 0.0000.00%
Close Sep 12 16:00 ET
367.82MMarket Cap-9671P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 24.875M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--
--2023/Q40.000 / 2.429M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 24.875M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--
--2023/Q40.000 / 2.429M--

Unlock Free Earnings Estimates

Aldeyra Therapeutics Earnings Reports

  • Aldeyra Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:10 ET

  • Aldeyra Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 2 16:10 ET

  • Aldeyra Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 16:10 ET

  • Aldeyra Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 12, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data